FDA Inspection 1036684 — Qilu Pharmaceutical (Hainan) Co. Ltd.
The FDA completed an inspection of Qilu Pharmaceutical (Hainan) Co. Ltd. on November 17, 2017 in Haikou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 17, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Haikou (China)